Application Nr Approved Date Route Status External Links
ANDA202229 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Acamprosate Calcium Delayed-Release Tablets Are Indicated For The Maintenance Of Abstinence From Alcohol In Patients With Alcohol Dependence Who Are Abstinent At Treatment Initiation. Treatment With Acamprosate Calcium Delayed-Release Tablets Should Be Part Of A Comprehensive Management Program That Includes Psychosocial Support. The Efficacy Of Acamprosate Calcium Delayed-Release Tablets In Promoting Abstinence Has Not Been Demonstrated In Subjects Who Have Not Undergone Detoxification And Not Achieved Alcohol Abstinence Prior To Beginning Acamprosate Calcium Delayed-Release Tablets Treatment. The Efficacy Of Acamprosate Calcium Delayed-Release Tablets In Promoting Abstinence From Alcohol In Polysubstance Abusers Has Not Been Adequately Assessed. • Acamprosate Calcium Delayed-Release Tablets Are Indicated For The Maintenance Of Abstinence From Alcohol In Patients With Alcohol Dependence Who Are Abstinent At Treatment Initiation ( 1 , 14 ). • Treatment With Acamprosate Calcium Delayed-Release Tablets Should Be Part Of A Comprehensive Management Program That Includes Psychosocial Support ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Acamprosate Calcium ACAMPROSATE CALCIUM ZINC1554588

Comments